Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 AUD | -1.75% | -1.75% | -34.12% |
Chart calendar Paradigm Biopharmaceuticals Limited
Upcoming events on Paradigm Biopharmaceuticals Limited
Past events on Paradigm Biopharmaceuticals Limited
2024-04-17 | OARSI World Congress |
2024-03-20 08:40 pm | NWR Virtual Healthcare Conference |
2024-02-27 08:15 pm | Q2 2024 Earnings Release |
2024-02-01 | Orthopaedic Research Society Meeting |
2024-01-30 04:48 pm | December 2023 Sales and Revenue Release - Activities Report |
2023-11-28 05:00 pm | Annual General Meeting |
2023-10-29 06:04 pm | September 2023 Sales and Revenue Release - Activities Report |
2023-10-17 | PARA_OA_008 Phase II Clinical Trial Results Call |
2023-10-09 | PARA_OA_008 Phase 2 clinical trial Results Call |
2023-08-25 01:53 am | Q4 2023 Earnings Release |
2023-07-30 09:58 pm | June 2023 Sales and Revenue Release - Activities Reporet |
2023-07-19 | MST Access Biotech Hidden Gems Forum |
2023-04-28 12:24 am | March 2023 Sales and Revenue Release - Activities Reporet |
2023-04-03 07:30 pm | PARA_OA_008 Clinical Trial Results Call |
2023-03-21 10:00 pm | NWR Virtual Healthcare Conference |
2023-03-16 | Osteoarthritis Research Society International World Congress |
2023-02-26 05:57 pm | Q2 2023 Earnings Release |
2023-02-21 | WORLD Symposium |
2023-02-19 | Lysosomal Diseases International Conference |
2023-01-30 | December 2022 Sales and Revenue Release - Activities Reporet |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 3,25 3,00 8.19% | 4,70 2,63 78.86% | 8,94 3,40 162.99% | 0,08 0,00 - | 0,05 0,01 367.6% | 0,00 |
EBITDA Million AUD | Released Forecast Spread | -8,69 -6,00 -44.84% | -12,1 -15,5 22% | -34,0 -35,0 2.58% | -39,0 -56,6 31.05% | -51,7 -59,0 12.31% | -52,5 |
EBIT Million AUD | Released Forecast Spread | -8,70 -6,00 -44.98% | -12,3 -15,5 20.62% | -34,3 -35,0 1.98% | -39,2 -56,6 30.71% | -51,9 -59,0 12.04% | -52,5 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -15,6 -5,80 -169.44% | -12,3 -14,4 14.6% | -34,3 -35,8 4.06% | -39,2 -55,4 29.15% | -51,9 -58,5 11.26% | -52,0 |
Net income Million AUD | Released Forecast Spread | -15,6 -5,80 -169.44% | -12,3 -14,4 14.6% | -34,3 -33,7 -1.92% | -39,2 -55,4 29.15% | -51,9 -58,5 11.26% | -52,0 |
EPS AUD | Released Forecast Spread | -0,11 -0,04 -187.63% | -0,06 -0,07 18.05% | -0,17 -0,15 -13.49% | -0,17 -0,24 30.29% | -0,21 -0,20 -3.9% | -0,18 |
Announcement Date | 30/08/19 | 27/08/20 | 26/08/21 | 25/08/22 | 25/08/23 | - |
Quarterly results
Fiscal Period | June | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 |
---|---|---|---|---|---|
EBITDA Million AUD | Released Forecast Spread | -13,4 -14,9 9.79% | |||
EBIT Million AUD | Released Forecast Spread | -13,5 -14,8 8.46% | -12,3 -29,6 58.61% | ||
Net income Million AUD | Released Forecast Spread | -20,7 | -27,0 | ||
EPS AUD | Released Forecast Spread | -0,09 | -0,12 | ||
Announcement Date | 24/02/21 | 26/08/21 | 23/02/22 | 25/08/22 |
Today 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Paradigm Biopharmaceuticals Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PAR Stock
- Calendar Paradigm Biopharmaceuticals Limited